Navigation Links
OncoSec to Evaluate Potential Predictive or Prognostic Biomarkers for Treatment of Solid Tumor Cancers Using OMS ElectroImmunotherapy
Date:3/8/2012

SAN DIEGO, March 8, 2012 /PRNewswire/ -- OncoSec Medical Incorporated (OTCBB:ONCS), which is developing its advanced-stage OncoSec Medical System (OMS) ElectroOncology therapies to treat solid tumor cancers, today announced that the company will be presenting its biomarker strategy with the goal of identifying and evaluating potential markers that may refine and enhance the selection of patients potentially responsive to the company's OMS ElectroImmunotherapy treatment.

(Logo:  http://photos.prnewswire.com/prnh/20110314/MM64943LOGO)

With the recent approvals of immunotherapies for metastatic castrate resistant prostate cancer and non-resectable metastatic melanoma, a shift in the development paradigm of cancer immunotherapies has occurred, and at the heart of this shift is the understanding that immunotherapies result in novel patterns of antitumor response, which are delayed compared to other conventional treatments. Therefore it is evident that measurable and reproducible biomarkers must be identified for use as either prognostic or predictive tools, thus allowing investigation of its relationship with clinical outcomes. Through collaboration with Serametrix Corporation, OncoSec Medical Inc. is attempting to decipher these biomarkers early in clinical development using novel profiling assays, for its electroporation-mediated delivery of the immunotherapeutic agent Interleukin-12 (IL-12).

Michael Cross, Ph.D., M.B.A., Chief Business Officer at OncoSec, will be presenting the company's strategy at the upcoming BioMarker Partnering & Deal-Making Conference during the BioMarker Summit 2012 in San Diego, March 15-16, 2012.

Biomarker Partnering & Deal-Making Conference 
Paradise Point Resort
1404
'/>"/>

SOURCE OncoSec Medical Incorporated
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. OncoSec Medical Licenses Non-DNA Vaccine Tumor Therapy Technology from Inovio Pharmaceuticals
2. Inovio Pharmaceuticals Licenses Non-DNA Vaccine Tumor Therapy Technology to OncoSec Medical
3. OncoSec Medical to Present at ROTH 23rd Annual Growth Stock Conference
4. OncoSec Medical Closes $1.1M Financing
5. OncoSec Medical Closes Purchase and License Agreement for Tumor Therapy Technology with Inovio Pharmaceuticals
6. OncoSec Medical Announces the Appointment of Dr. Anthony E. Maida, III, to Its Board of Directors
7. OncoSec Medical Appoints Engineering Leader
8. OncoSec Medical to Present at Industry and Investor Conferences
9. OncoSec Medical to Attend 6th Annual Fire, Ice and Beyond: The Future of Ablation Therapies Conference
10. OncoSec Announces Positive Results from Head & Neck and Breast Cancer Trials
11. Update: OncoSec Announces Positive Results From Head & Neck and Breast Cancer Trials
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/17/2015)... and Markets ( http://www.researchandmarkets.com/research/lmsnqn/medical_equipment ) has announced ... Leasing - Global Strategic Business Report" report to ... markets for Medical Equipment Rental and Leasing in US$ ... US, Japan , Europe ... estimates and forecasts are provided for the period 2014 ...
(Date:4/17/2015)... DIEGO , April 17, 2015  Trovagene, ... diagnostics, announced today that clinical data presented at ... that its urine-based Precision Cancer Monitoring ℠ ... and monitoring of EGFR T790M mutations ... Detection of EGFR T790M Mutation in Urinary ...
(Date:4/17/2015)... 17, 2015 Research and Markets ( ... "Medical Oxygen Systems - Global Strategic Business Report" ... the worldwide markets for Medical Oxygen Systems in US$ ... Systems, Oxygen Cylinders & Regulators, and Oxygen Conserving Devices. ... Canada , Japan ...
Breaking Medicine Technology:Medical Equipment Rental and Leasing Market 2015-2020 - Global Strategic Business Report - Healthcare Spending Slowdown Bodes Well for Medical Equipment Leasing 2Trovagene's Urinary ctDNA Assay Outperforms Tissue Biopsy in Clinical Study for the Detection of EGFR T790M Mutations in Metastatic Lung Cancer Patients 2Trovagene's Urinary ctDNA Assay Outperforms Tissue Biopsy in Clinical Study for the Detection of EGFR T790M Mutations in Metastatic Lung Cancer Patients 3Trovagene's Urinary ctDNA Assay Outperforms Tissue Biopsy in Clinical Study for the Detection of EGFR T790M Mutations in Metastatic Lung Cancer Patients 4Medical Oxygen Systems - 2015 Global Strategic Business Report Featuring Leading Players, Caire, Invacare & Philips Respironics 2
... Care Pharmacy Alliance,s (LTCPA) recent study, "Measurement of Unused ... has been published in the September 2011 issue of ... American Society of Consultant Pharmacists. This is the first ... value of unused solid oral dosage from prescription drugs ...
... RIDGEFIELD, Conn. and INDIANAPOLIS, Sept. 7, 2011 ... LLY ) will present the latest ... Annual Meeting of the European Association for the ... 12-16. Study results evaluating the dipeptidyl peptidase-4 (DPP-4) ...
Cached Medicine Technology:LTCPA Study Quantifying Unused Medicare Part D Drugs in Skilled Nursing Facilities Published in The Consultant Pharmacist 2Boehringer Ingelheim and Lilly to Feature Type 2 Diabetes Research in Presentations at the 47th Annual Meeting of the European Association for the Study of Diabetes 2Boehringer Ingelheim and Lilly to Feature Type 2 Diabetes Research in Presentations at the 47th Annual Meeting of the European Association for the Study of Diabetes 3Boehringer Ingelheim and Lilly to Feature Type 2 Diabetes Research in Presentations at the 47th Annual Meeting of the European Association for the Study of Diabetes 4Boehringer Ingelheim and Lilly to Feature Type 2 Diabetes Research in Presentations at the 47th Annual Meeting of the European Association for the Study of Diabetes 5Boehringer Ingelheim and Lilly to Feature Type 2 Diabetes Research in Presentations at the 47th Annual Meeting of the European Association for the Study of Diabetes 6
(Date:4/18/2015)... (PRWEB) April 18, 2015 On April 14th, ... Threat Report , which they say, “exposes a tactical shift ... new malware variants were introduced in 2014 - almost a ... Zero Day threats to be identified and patched by prominent ... abundantly clear that doing business in a digital world can ...
(Date:4/17/2015)... April 18, 2015 Heritage Woods of ... its Supportive Living Week Celebration on April 20 with ... a healthy mind, body and soul. , The community, ... Illinois, serves older adults of all incomes, including those ... independence. , Supportive Living Week is observed every April ...
(Date:4/17/2015)... Oklahoma (PRWEB) April 17, 2015 Alcohol ... Drug Dependence (NCADD) notes that drinking and driving has ... At the same time, the link between alcohol ... as domestic abuse and violence and sexual assault, and ... According to the NCADD, 5.3 million adults in America ...
(Date:4/17/2015)... 17, 2015 Consumers who prefer to ... modifications can now use the Insurance Pros USA website ... policy rates that are featured by leading companies quoting ... that are offered are mixed between three of the ... 79. There are now term, universal and whole policies ...
(Date:4/17/2015)... 2015 Most dental patients are not ... are made overseas by foreign dental laboratories, according to ... unregulated in more than 40 states by their respective ... of Dental Laboratories has created the “What’s ... patients about the consequences that could be associated with ...
Breaking Medicine News(10 mins):Health News:Cyber Attackers Continue to Fine Tune Deception and Stealth Tactics According to New Report 2Health News:Cyber Attackers Continue to Fine Tune Deception and Stealth Tactics According to New Report 3Health News:Cyber Attackers Continue to Fine Tune Deception and Stealth Tactics According to New Report 4Health News:Cyber Attackers Continue to Fine Tune Deception and Stealth Tactics According to New Report 5Health News:Heritage Woods of McLeansboro Affordable Assisted Living to Celebrate Supportive Living Week 2Health News:Heritage Woods of McLeansboro Affordable Assisted Living to Celebrate Supportive Living Week 3Health News:Narconon Arrowhead Raises Awareness on Alcohol Related Prevention 2Health News:Narconon Arrowhead Raises Awareness on Alcohol Related Prevention 3Health News:General Life Insurance Policy Rates Added to Quotation System at Insurance Website Online 2Health News:National Association Urges Transparency in Dental Industry 2
... and heart attack injury by maintaining Adenosine Tri Phosphate ... with rapamycin - an antibiotic (used to trigger organ ... have revealed that heart tissue damage after an acute ... ,In the July issue of the Journal of Molecular ...
... botox – an anti-wrinkle treatment, Dr Frederic Meunier, ... a cure for motoneuronal diseases//. ,Researcher ... system in the body, which blocked the unnecessary ... motorneuron diseases. ,Motoneuronal diseases cause a ...
... York: A new study claims that patients with stomach cancer ... survival rates//. ,The study that was published in ... has reported that chemotherapy could reduce the risk of death ... It was also stated that chemo helped in shrinking the ...
... Johnson Medical School in New Brunswick, New Jersey have ... indulge in bed wetting //as children since they seem ... biological plausibility in inferring that breast-feeding protects against bed-wetting ... researchers said. They added that there was sufficient evidence ...
... in China, doctors have successfully transplanted the heart of ... organs from people whom Chinese traditionally do not consider ... a heart extracted from a brain-dead patient, the surgery ... director of Institute of Organ Transplantation of Tongji Hospital ...
... in Meghalaya so far this year, state Health minister E ... to a calling attention notice, Marak said 11 deaths were ... from East Garo Hills, nine died in West Khasi, four ... ,This year, there has been a "more serious" incidence of ...
Cached Medicine News:Health News:Antibiotic Proved Protective against Heart Tissue Damage and Cell Death – Research Find 2
Plastic Citrate Tube, .109M / 3.2%...
Inquire...
... EDTA K2 or EDTA K3 tubes. ... therefore blocks the coagulation cascade. Erythrocytes, ... anticoagulated blood sample are stable for ... are for the examination of whole ...
... Tissue transglutaminase (tTg) is a ... of proteins. Tissue transglutaminase is also ... by the endomysial antibody immunofluorescence (EMA) ... 29060). Anti-tTg IgA and,IgG serologic tests ...
Medicine Products: